Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer

The rebel angel: mutant p53 as the driving oncogene in breast cancer

(2012) D. Walerych et al.   CARCINOGENESIS

Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations

(2012) Tobias Rausch et al.   CELL

Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop

(2012) Fabio Valenti et al.   CELL CYCLE

Stathmin Is Dispensable for Tumor Onset in Mice

(2012) Sara D’Andrea et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer

(2011) Javier E. Girardini et al.   CANCER CELL

Stathmin: a protein with many tasks. New biomarker and potential target in cancer

(2011) Barbara Belletti et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas

(2011) Alison M. Karst et al.   GYNECOLOGIC ONCOLOGY

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

(2011) Robert J. Kurman et al.   HUMAN PATHOLOGY

p53 and its mutants in tumor cell migration and invasion

(2011) Patricia A. J. Muller et al.   JOURNAL OF CELL BIOLOGY

Bub1 and BubR1: at the Interface between Chromosome Attachment and the Spindle Checkpoint

(2011) S. Elowe   MOLECULAR AND CELLULAR BIOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Centromeres: unique chromatin structures that drive chromosome segregation

(2011) Jolien S. Verdaasdonk et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer

(2010) Jean-Philippe Meyniel et al.   BMC CANCER

The role of mutant p53 in human cancer

(2010) Amanda M Goh et al.   JOURNAL OF PATHOLOGY

A Role of DNA-PK for the Metabolic Gene Regulation in Response to Insulin

(2009) Roger H.F. Wong et al.   CELL

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL

Ovarian carcinoma pathology and genetics: recent advances

(2009) C. Blake Gilks et al.   HUMAN PATHOLOGY

Activation of DNA-PK by Ionizing Radiation Is Mediated by Protein Phosphatase 6

(2009) Jun Mi et al.   PLoS One

Mutant p53 Gain-of-Function in Cancer

(2009) M. Oren et al.   Cold Spring Harbor Perspectives in Biology

Ovarian Cancer Pathogenesis: A Model in Evolution

(2009) Alison M. Karst et al.   Journal of Oncology

Peptide Aptamers Targeting Mutant p53 Induce Apoptosis in Tumor Cells

(2008) E. Guida et al.   CANCER RESEARCH

The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss

(2008) T. Terzian et al.   GENES & DEVELOPMENT

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

(2008) Charles N. Landen et al.   JOURNAL OF CLINICAL ONCOLOGY

Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors

(2008) M. S. Anglesio et al.   MOLECULAR CANCER RESEARCH

p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis

(2008) M. Schiappacassi et al.   MOLECULAR CANCER THERAPEUTICS

RCS1, a substrate of APC/C, controls the metaphase to anaphase transition

(2008) W.-m. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation

(2008) E. Huston et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA